← Back to Clinical Trials
Recruiting NCT06858345

NCT06858345 Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06858345
Status Recruiting
Phase
Sponsor Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Condition Preeclampsia
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2025-01-01
Primary Completion 2026-01-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2025-01-01 with a primary completion date of 2026-01-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

Eligibility Criteria

Inclusion Criteria: * Age greater than or equal to 18 years * Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy. Exclusion Criteria: * Minors under 18 years of age. * Women with mental disabilities. * Major congenital fetal anomaly.

Contact & Investigator

Central Contact

Catalina de Paco Matallana, MD

✉ katy.depaco@gmail.com

📞 968369500

Frequently Asked Questions

Who can join the NCT06858345 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Preeclampsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06858345 currently recruiting?

Yes, NCT06858345 is actively recruiting participants. Contact the research team at katy.depaco@gmail.com for enrollment information.

Where is the NCT06858345 trial being conducted?

This trial is being conducted at El Palmar, Spain.

Who is sponsoring the NCT06858345 clinical trial?

NCT06858345 is sponsored by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology